PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'School of Law, University of Tasmania, Hobart, Australia.\', \'Clinical Center Department of Bioethics & Division of AIDS, National Institutes of Health, Bethesda, MarylandUSA.\', \'Health Systems and Research Ethics (HSRE) Department, Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme, Nairobi, Kenya.\', \'Department of Pediatrics, Chicago, IllinoisUSA.\', \'Mary Ann & J. Milburn Smith Child Health Outcomes, Research, and Evaluation (SCHORE) Center; Stanley Manne Children\'s Research Institute; Lurie Children\'s Hospital, Chicago, IllinoisUSA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/cid/ciab239
?:doi
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 33758912
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • The Essential Role of Data and Safety Monitoring Boards (DSMBs) in Ensuring the Ethics of Global Vaccine Trials to Address Coronavirus Disease 2019 (COVID-19O).
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all